US anti-virals giant Gilead Sciences late yesterday announced its third quarter 2025 results of operations, reporting total ...

King Faisal Specialist Hospital & Research Centre (KFSHRC) has begun in-house manufacturing and clinical use of CAR-T cell ...

An Austrian biotech company developing protein-conjugation technologies aimed at accelerating vaccine and therapeutic ...

The top 20 global biopharmaceutical companies saw their combined market capitalization rise 4% in the third quarter of 2025 ...

US biotech 4D Molecular Therapeutics (Nasdaq: FDMT) has granted Japan’s Otsuka Pharmaceutical (TYO: 4578) exclusive rights to ...

German family-owned pharma major Boehringer Ingelheim has licensed a pre-clinical program from Japan’s Kyowa Kirin to develop ...

The US Health Resources and Services Administration (HRSA) has approved nine drugs for a pilot testing a new rebate model ...

Swiss pharma major Roche (ROG: SIX) has entered a global exclusive licensing agreement with China’s Qyuns Therapeutics for ...

China’s R&D and manufacturing services provider WuXi AppTec has reached agreement for Hillhouse Investment Management to ...

Merck & Co (NYSE: MRK) posted third-quarter 2025 revenue of $17.3 billion, up 4% year over year, while adjusted earnings rose ...

Germany-based biotech Tubulis today announced a second and final closing of its Series C round totaling 344 million euros ...

US pharma major Eli Lilly today announced its financial results for the third-quarter of 2025, exceeding expectations and ...